Search

Search Constraints

You searched for: Author/Creator Ganzel, Chezi

Search Results

1. At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial. (27th March 2020)

2. Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long‐term follow‐up of a multi‐center prospective study. Issue 1 (17th October 2019)

3. Characteristics and outcome of multiple myeloma patients presenting with anaemia only: A retrospective multi-centre study. (February 2021)

4. Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group. Issue 14 (6th December 2022)

5. Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study. (16th November 2015)

7. Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling. (December 2022)

8. Midostaurin in combination with chemotherapy is most effective in patients with acute myeloid leukemia presenting with high FLT3‐ITD allelic ratio who proceed to allogeneic stem cell transplantation while in first complete remission. (6th October 2020)

9. Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16). Issue 8 (6th February 2019)